LINE
REAL ESTATELineage Inc
Live · NASDAQ · May 9, Close
What's Moving LINE Today?
No stock-specific AI insight has been generated for LINE yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$37.81
Fundamentals
Trading
LINE News
20 articles- Is It Time To Reassess Lineage (LINE) After Recent Share Price Recovery?Yahoo Finance·May 7, 2026
- Lineage, Inc. Q1 2026 Earnings Call SummaryMoby·May 6, 2026
- Lineage Q1 Earnings Call HighlightsMarketbeat·May 6, 2026
- Lineage (LINE) Q1 2026 Earnings Call TranscriptMotley Fool·May 6, 2026
- Lineage says cold storage market working through oversupplyYahoo Finance·May 6, 2026
- Lineage (LINE) misses quarterly expectations as warehouse occupancy pressures continueAdvfn·May 6, 2026
- Lineage, Inc. (LINE) Q1 FFO Beat EstimatesYahoo Finance·May 6, 2026
- Lineage, Inc. Reports First-Quarter 2026 Financial ResultsYahoo Finance·May 6, 2026
- Assessing Lineage (LINE) Valuation After Recent Share Price Weakness And Cold Storage Growth OutlookYahoo Finance·Apr 10, 2026
- Lineage, Inc. Announces Chief Information Officer and Chief Transformation Officer Retirement and Transition PlanYahoo Finance·Apr 9, 2026
- All You Need to Know About Lineage, Inc. (LINE) Rating Upgrade to BuyYahoo Finance·Apr 8, 2026
- Lineage to Report First-Quarter 2026 Financial Results on May 6, 2026Yahoo Finance·Apr 2, 2026
- Lineage, Inc. Declares Increased Dividend for First-Quarter 2026Yahoo Finance·Mar 13, 2026
- Lineage (LINE) Price Target Increased to $44 by RBC Capital on Q4 FFO StrengthYahoo Finance·Mar 10, 2026
- Assessing Lineage (LINE) Valuation After Recent Share Price Momentum ShiftYahoo Finance·Mar 1, 2026
- Lineage Q4 Earnings Call HighlightsMarketbeat·Feb 25, 2026
- Lineage Inc (LINE) Q4 2025 Earnings Call Highlights: Navigating Challenges with Strategic ...Yahoo Finance·Feb 25, 2026
- Lineage, Inc. Q4 2025 Earnings Call SummaryMoby·Feb 25, 2026
- Lineage, Inc. (LINE) Reports Q4 Earnings: What Key Metrics Have to SayYahoo Finance·Feb 25, 2026
- Lineage, Inc. (LINE) Beats Q4 FFO EstimatesYahoo Finance·Feb 25, 2026
All 20 articles loaded
Price Data
52-Week Range
$37.81
Fundamentals
Trading
About Lineage Inc
Lineage, Inc. (Ticker: LINE) is a pioneering biotechnology firm focused on regenerative medicine, specifically developing cutting-edge cell therapy solutions for treating debilitating conditions, including ocular diseases, spinal cord injuries, and various cancers. With its proprietary technologies and robust network of strategic collaborations, Lineage is poised to transform patient care through innovative therapeutic interventions. The company's commitment to advancing its diverse product pipeline and expediting clinical research positions it as an attractive investment opportunity for institutional investors seeking to engage in the forefront of healthcare advancements.